Journal
BIOCHEMISTRY
Volume 45, Issue 32, Pages 9833-9840Publisher
AMER CHEMICAL SOC
DOI: 10.1021/bi060779a
Keywords
-
Categories
Ask authors/readers for more resources
W7 is a well-known calmodulin (CaM) antagonist and has been implicated as an inhibitor of the troponin C-mediated Ca2+ activation of cardiac muscle contraction. In this study, we use NMR spectroscopy to study binding of W7 to cardiac troponin C (cTnC) free or in complex with cardiac troponin I (cTnI) peptides. Titration of cTnC, 3Ca(2+) with W7 shows that residues throughout the sequence, including the N- and C-domains of cTnC and the central linker, are affected. Analysis of the binding stoichiometry and the trajectories of chemical shift changes indicate that W7 binding occurs at multiple sites. To address the issue of whether multiple-site binding is relevant within the troponin complex, W7 is titrated to a cTnC-cTnI complex (cTnC, 3Ca(2+), cTnI(34-71), cTnI(128-163)). In the presence of the N- terminal ( residues similar to 34-71), inhibitory (residues similar to 128-147), and switch (residues similar to 147-163) regions of cTnI, W7 induces chemical shift changes only in the N- domain and not in the C-domain or the central linker of cTnC. The results indicate that in the presence of cTnI, W7 no longer binds to multiple sites of cTnC but instead binds specifically to the N- domain, and the binding (K-D = 0.5 +/- 0.1 mM) can occur together with the switch region of cTnI. Hence, W7 may play a role in directly modulating the Ca2+ sensitivity of the regulatory domain of cTnC and the interaction of the switch region of cTnI and cTnC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available